SUSAN LOWRY: Open Payments
NPI 1871592287 · MARTIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$655 in 27 payments from 9 companies in 2025. Trend: 2023 $529 · 2024 $729 · 2025 $655
Food & beverage: $610Education: $45
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $210 |
| AstraZeneca Pharmaceuticals LP | 5 | $116 |
| Otsuka America Pharmaceutical, Inc. | 6 | $111 |
| Exact Sciences Corporation | 3 | $63 |
| Dexcom, Inc. | 2 | $50 |
| Lilly USA, LLC | 1 | $45 |
| Verona Pharma, Inc. | 1 | $24 |
| Seqirus USA Inc | 1 | $20 |
| Baxter Healthcare | 1 | $15 |
Products named: Ozempic, REXULTI, FARXIGA, Cologuard Collection Kit, Dexcom G6 Transmitter, Ohtuvayre, BREZTRI, Flucelvax.
Industry payments across TN — which companies pay providers there.
